These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30625015)

  • 21. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence, quality of life, and satisfaction with conventional fix combined therapy versus maintenance and reliever therapy in patients with asthma after inhaler training.
    Sekibağ Y; Borekci S; Gemicioglu B
    J Asthma; 2022 Sep; 59(9):1819-1830. PubMed ID: 34388078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD.
    Plaza V; Giner J; Curto E; Alonso-Ortiz MB; Orue MI; Vega JM; Cosío BG;
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):645-653. PubMed ID: 31586668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of salbutamol efficacy in children--via the metered-dose inhaler (MDI) with Volumatic spacer and via the dry powder inhaler, Easyhaler, with the nebulizer--in mild to moderate asthma exacerbation: a multicenter, randomized study.
    Direkwatanachai C; Teeratakulpisarn J; Suntornlohanakul S; Trakultivakorn M; Ngamphaiboon J; Wongpitoon N; Vangveeravong M
    Asian Pac J Allergy Immunol; 2011 Mar; 29(1):25-33. PubMed ID: 21560485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
    Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
    BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.
    Welch MJ
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1109-19. PubMed ID: 27424535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of real-life data on the use of inhaler devices, including satisfaction and adherence to treatment, by community pharmacists in partnership with pulmonary disease specialists.
    Gemicioglu B; Gungordu N; Can G; Alp Yıldırım FI; Uydeş Doğan BS
    J Asthma; 2023 Jul; 60(7):1326-1335. PubMed ID: 36332164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.
    Karampitsakos T; Hillas G; Zervas E; Bakakos P; Stratakos G; Dimakou K; Manali E; Bouros D; Papiris S; Tzouvelekis A;
    Pulm Pharmacol Ther; 2020 Feb; 60():101882. PubMed ID: 31881275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD.
    De Simón Gutiérrez R; Castro RP
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):151-161. PubMed ID: 36087251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
    Roche N; Aggarwal B; Boucot I; Mittal L; Martin A; Chrystyn H
    Respir Med; 2022 Oct; 202():106949. PubMed ID: 36063773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between inhaler technique and asthma control among asthma patients using pressurised MDIs and DPIs.
    Basheti IA; Obeidat NM; Ammari WG; Reddel HK
    Int J Tuberc Lung Dis; 2016 May; 20(5):689-95. PubMed ID: 27084826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.
    Hira D; Koide H; Nakamura S; Okada T; Ishizeki K; Yamaguchi M; Koshiyama S; Oguma T; Ito K; Funayama S; Komase Y; Morita SY; Nishiguchi K; Nakano Y; Terada T
    PLoS One; 2018; 13(2):e0193082. PubMed ID: 29462195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dry powder inhalers - between the doctor and the patient.
    Emeryk A; Pirożyński M; Emeryk-Maksymiuk J
    Adv Respir Med; 2018; 86(1):44-52. PubMed ID: 29490421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Easyhalers in practice for treating patients with asthma].
    Panina NT; Il'kovich MM
    Ter Arkh; 2013; 85(3):98-101. PubMed ID: 23720852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.